Not logged in Fiber Intake and Diet Health Index of Recipients as Modulators of FMT Response in UC: A Post Hoc Analysis Deleu, S.; Vazquezcastellanos, J. F.; Derrien, M.; Caenepeel, C.; Vissers, E.; Arnauts, K.; Verstockt, S.; Proost, S.; Baert, F. J.; Mana, F.; Pouillon, L.; Lobaton Ortega, T.; Louis, E.; Franchimont, D.; Verstockt, B.; Ferrante, M.; Vermeire, S.; Raes, J.; Guedelha Sabino, J. Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Effect of the dietary emulsifier κ-carrageenan on the inflammatory state and permeability of intestinal epithelial cells from patients with Crohn's disease Vissers, E.; Wellens, J.; Giorio, L.; Zadora, W.; Verstockt, B.; Ferrante, M.; Vermeire, S.; Matthys, C.; Arnauts, K.; Sabino, J. Share Save
Share Save
Efficacy and Safety of Risankizumab in Patients With Moderate to Severe Crohn's Disease With 3 Years of Treatment: Results From the FORTIFY Open-Label Long-Term Extension Ferrante, M.; Panaccione, R.; Colombel, J. F.; Dubinsky, M. C.; Hisamatsu, T.; Lindsay, J. O.; Song, A.; Yao, Y.; Zhang, Y.; Zambrano, J.; Aponte, F.; Duan, W. R.; D'Haens, G. Share Save
Food-related quality of life is worse in Crohn's disease, stricturing disease and those with a surgical history: development and validation of the FR-QoL-29-Dutch (Flemish) questionnaire Wellens, J.; Guadagnoli, L.; Vanderstappen, J.; Hoekx, S.; Vandaele, J.; Ferrante, M.; Verstockt, B.; Vermeire, S.; Whelan, K.; Sabino, J. Share Save
P1008 Subcutaneous infliximab in IBD patients previously treated with an optimized intravenous infliximab dosing schedule: preliminary results on expectations and satisfaction of switching from intravenous to subcutaneous infliximab Moens, A.; Holvoet, T.; Bossuyt, P.; Lobaton, T.; Posen, A.; Cremer, A.; Capirchio, L.; Caenepeel, C.; Lambrecht, G.; Amezaga, A. J.; Reenaers, C.; Peeters, H.; Willandt, B.; Deprez, N.; De Rechter, J.; Arijs, I; Straetemans, N.; Dreesen, E.; Ferrante, M. Share Save
Share Save
Positive effects of a mindfulness-based intervention on depression, stress and perceived control, but not on disability in patients with Crohn's disease: results from a randomized controlled trial Keersmaekers, B.; Beeckmans, D.; Brams, S.; Vanderbist, K.; van den Bosch, M.; Vermeire, S.; Verstockt, B.; Sabino, J.; Van Diest, I; Ferrante, M. Share Save
Low remission recapture after ustekinumab dose optimization in Crohn's disease: results of the randomized placebo-controlled double-blind REScUE study. Bossuyt, P.; Rahier, J. F.; Baert, F.; Louis, E.; Macken, E.; Lobaton, T.; Busschaert, J.; Peeters, H.; Dewint, P.; Franchimont, D.; Dutre, J.; Willandt, B.; Claessens, C.; Dewit, O.; Ferrante, M.; Vermeire, S. Share Save
APPROPRIATENESS OF UPPER ENDOSCOPY OUTPATIENT PRESCRIPTIONS IN A HIGH-VOLUME ENDOSCOPIC UNIT Rodriguez-Castro, K. I.; Franceschi, M.; Sella, D.; Ferronato, A.; Cuoco, L.; Ferrante, M.; Panozzo, M. P.; Di Mario, F.; Miraglia, C.; Antico, A.; Baldassarre, G. Share Save
Share Save
Share Save
Share Save
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
